Stevanato Group SpA (STVN)
19.46
-0.18
(-0.92%)
USD |
NYSE |
Oct 28, 16:00
19.46
0.00 (0.00%)
After-Hours: 20:00
Stevanato Group Enterprise Value : 5.781B for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 5.781B |
| October 26, 2026 | 5.846B |
| October 23, 2026 | 5.740B |
| October 22, 2026 | 5.743B |
| October 21, 2026 | 5.557B |
| October 20, 2026 | 5.609B |
| October 19, 2026 | 5.611B |
| October 16, 2026 | 5.579B |
| October 15, 2026 | 5.674B |
| October 14, 2026 | 5.691B |
| October 13, 2026 | 5.677B |
| October 12, 2026 | 5.672B |
| October 09, 2026 | 5.715B |
| October 08, 2026 | 5.663B |
| October 07, 2026 | 5.726B |
| October 06, 2026 | 5.841B |
| October 05, 2026 | 5.893B |
| October 02, 2026 | 5.934B |
| October 01, 2026 | 5.874B |
| September 30, 2026 | 6.147B |
| September 29, 2026 | 6.207B |
| September 28, 2026 | 6.264B |
| September 25, 2026 | 6.188B |
| September 24, 2026 | 6.256B |
| September 23, 2026 | 6.341B |
| Date | Value |
|---|---|
| September 22, 2026 | 6.343B |
| September 21, 2026 | 6.292B |
| September 18, 2026 | 6.343B |
| September 17, 2026 | 6.608B |
| September 16, 2026 | 6.570B |
| September 15, 2026 | 6.300B |
| September 14, 2026 | 6.240B |
| September 11, 2026 | 6.125B |
| September 10, 2026 | 6.139B |
| September 09, 2026 | 5.945B |
| September 08, 2026 | 5.967B |
| September 04, 2026 | 6.018B |
| September 03, 2026 | 6.027B |
| September 02, 2026 | 6.079B |
| September 01, 2026 | 6.073B |
| August 31, 2026 | 6.270B |
| August 28, 2026 | 6.160B |
| August 27, 2026 | 6.507B |
| August 26, 2026 | 6.529B |
| August 25, 2026 | 6.617B |
| August 24, 2026 | 6.499B |
| August 21, 2026 | 6.589B |
| August 20, 2026 | 6.521B |
| August 19, 2026 | 6.346B |
| August 18, 2026 | 6.207B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 52.24B |
| Bio-Rad Laboratories, Inc. | 9.937B |
| Bruker Corp. | 10.91B |
| Danaher Corp. | 185.30B |
| Harvard Bioscience, Inc. | 75.71M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 26.69M |
| Revenue (Quarterly) | 351.14M |
| Total Expenses (Quarterly) | 324.45M |
| EPS Diluted (Quarterly) | 0.0978 |
| Gross Profit Margin (Quarterly) | 27.86% |
| Profit Margin (Quarterly) | 7.60% |
| Earnings Yield | 2.96% |
| Operating Earnings Yield | 4.48% |
| Normalized Earnings Yield | 3.043 |